Article
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
The American journal of pathology - 1 Mar 2014
Tsourlakis Maria C, Weigand Philipp, Grupp Katharina, Kluth Martina, Steurer Stefan, Schlomm Thorsten, Graefen Markus, Huland Hartwig, Salomon Georg, Steuber Thomas, Wilczak Waldemar, Sirma Hüseyin, Simon Ronald, Sauter Guido, Minner Sarah, Quaas Alexander
Abstract excerpt
Evidence suggests that class III β-tubulin (βIII-tubulin) may represent a prognostic and predictive molecular marker in prostate cancer. βIII-Tubulin expression was determined by IHC in 8179 prostate cancer specimens in a TMA format. Results were compared with tumor phenotype, biochemical recurrence, v-ets avian erythroblastosis virus E26 oncogene homolog (ERG) status, and deletions on PTEN, 3p13, 5q21, and 6q15....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
